SCHEMBL9026332

SCHEMBL9026332

Clc1ncnc(-c2ccccc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 5/20 0.43
HPGD P15428 4/20 0.43
ALDH1A1 P00352 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
MAPK1 P28482 1/20 0.42
KDM4E B2RXH2 1/20 0.42
GLA P06280 1/20 0.42
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
POLB P06746 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA2B P29275 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29623718 0.96 SMN1; SMN2 (0.43) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL21295404 0.96 SMN1; SMN2 (0.43) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL29623745 0.96 SMN1; SMN2 (0.43) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL17445455 0.88 ALDH1A1 (0.42) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL21436898 0.87 GP6 (0.42) LMNAKMT2AMEN1SMN1; SMN2HPGD
SCHEMBL28528659 0.84 CYP2A6 (0.42) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL56387 0.84 L3MBTL1 (0.54) LMNAKMT2AMEN1HTTSMN1; SMN2
Morpholine SCHEMBL8170017 0.82 HTR2C (0.40) LMNAKMT2AMEN1HTTSMN1; SMN2
Ammonia Solution, Strong SCHEMBL28360184 0.81 L3MBTL1 (0.52) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL29240236 0.81 CYP2A6 (0.39) LMNAKMT2AMEN1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110041279-A A kind of conjugation diamine monomer and its synthetic method 江汉大学 2019-07-23 CN claimed
CN-109942551-A Organic molecule, especially its purposes in optoelectronic device 辛诺拉有限公司 2019-06-28 CN claimed
CN-108640881-A A kind of diamine monomer and its synthetic method 江汉大学 2018-10-12 CN claimed
EP-0051067-A1 TRIAZINE SYNTHESIS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 1982-05-12 EP claimed
WO-1981003020-A1 TRIAZINE SYNTHESIS COMMW SCIENT IND RES ORG (AU) 1981-10-29 WO claimed
CN-117143030-B Naphthyl substituted electricity-absorbing fragment compound, electron transport material and application 烟台显华科技集团股份有限公司 2026-05-12 CN disclosed
US-12545679-B2 Compound, material for an organic electroluminescence device and an organic electroluminescence device comprising the compound IDEMITSU KOSAN CO., LTD. (JP) 2026-02-10 US disclosed
US-12457900-B2 Organic compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2025-10-28 US disclosed
CN-116444468-B Anthracene derivative, organic electroluminescent material, light-emitting device and consumer product 浙江八亿时空先进材料有限公司 2025-05-06 CN disclosed
EP-4544888-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES Merck Patent GmbH (DE) 2025-04-30 EP disclosed
CN-119350335-B Material with benzopyridine acridine structure and application thereof 烟台九目化学股份有限公司 2025-04-11 CN disclosed
CN-115594705-B Compound for organic photoelectric device, composition for organic photoelectric device, and display device 三星SDI株式会社 2025-03-25 CN disclosed
EP-0405782-A1 Fungicides ZENECA LIMITED (GB) 1991-01-02 EP disclosed
EP-0053743-B1 REACTIVE DIOXAZINE DYESTUFFS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN DYEING AND PRINTING FIBROUS MATERIALS CONTAINING HYDROXYLE OR AMIDE GROUPS BAYER AG (DE) 1986-05-14 EP disclosed
US-4497951-A Ethynyl-phenylene-substituted-1,3,5-triazine derivatives and process for their production HUGHES AIRCRAFT COMPANY (US) 1985-02-05 US disclosed
US-4442278-A Ethynyl-substituted s-triazine derivatives, polymers thereof and process for making the same HUGHES AIRCRAFT COMPANY (US) 1984-04-10 US disclosed
US-4400504-A DYEING AND PRINTING CELLULOSE AND POLYAMIDE AND-URETHANE FIBERS; TRIAZINE, PYRIDINE AND PYRIMIDINE DYES BAYER AKTIENGESELLSCHAFT (DE) 1983-08-23 US disclosed
EP-0053743-A2 Reactive dioxazine dyestuffs, process for their preparation and their use in dyeing and printing fibrous materials containing hydroxyle or amide groups BAYER AG (DE) 1982-06-16 EP disclosed
EP-0051067-A1 TRIAZINE SYNTHESIS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 1982-05-12 EP disclosed
WO-1981003020-A1 TRIAZINE SYNTHESIS COMMW SCIENT IND RES ORG (AU) 1981-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12457900-B2 Organic compound, and electronic element and electronic device using same OR10J3, AOC2, EPCAM LMNA 1923/4885KMT2A 1952/4885MEN1 2257/4885
US-12545679-B2 Compound, material for an organic electroluminescence device and an organic electroluminescence device comprising the compound KCNJ2, KCNH1, KCNH2 LMNA 1603/4885KMT2A 1080/4885MEN1 998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.